HUE046410T2 - Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával - Google Patents

Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával

Info

Publication number
HUE046410T2
HUE046410T2 HUE14742021A HUE14742021A HUE046410T2 HU E046410 T2 HUE046410 T2 HU E046410T2 HU E14742021 A HUE14742021 A HU E14742021A HU E14742021 A HUE14742021 A HU E14742021A HU E046410 T2 HUE046410 T2 HU E046410T2
Authority
HU
Hungary
Prior art keywords
antagonist
administering
methods
nasal polyposis
treating nasal
Prior art date
Application number
HUE14742021A
Other languages
English (en)
Inventor
Leda Mannent
Gianluca Pirozzi
Allen Radin
Namita Gandhi
Robert Evans
Original Assignee
Sanofi Biotechnology
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Biotechnology, Regeneron Pharma filed Critical Sanofi Biotechnology
Publication of HUE046410T2 publication Critical patent/HUE046410T2/hu

Links

HUE14742021A 2013-06-21 2014-06-20 Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával HUE046410T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361837912P 2013-06-21 2013-06-21
EP14305670 2014-05-07

Publications (1)

Publication Number Publication Date
HUE046410T2 true HUE046410T2 (hu) 2020-03-30

Family

ID=66440559

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14742021A HUE046410T2 (hu) 2013-06-21 2014-06-20 Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával

Country Status (10)

Country Link
JP (3) JP6640977B2 (hu)
DK (1) DK3010539T3 (hu)
ES (1) ES2747630T3 (hu)
HR (1) HRP20191709T1 (hu)
HU (1) HUE046410T2 (hu)
LT (1) LT3010539T (hu)
NZ (1) NZ631118A (hu)
PT (1) PT3010539T (hu)
SG (1) SG10201912898XA (hu)
TW (1) TWI707694B (hu)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
EP2414520A2 (en) * 2009-03-31 2012-02-08 Altair Therapeutics, Inc. Methods of modulating an immune response to a viral infection
UA111731C2 (uk) * 2010-10-06 2016-06-10 Рідженерон Фармасьютікалз, Інк. Стабілізована композиція, яка містить антитіло до рецептора інтерлейкіну-4 (іl-4r), варіанти
CN111437387A (zh) * 2013-06-21 2020-07-24 赛诺菲生物技术公司 通过施用il-4r拮抗剂治疗鼻息肉症的方法

Also Published As

Publication number Publication date
ES2747630T3 (es) 2020-03-11
TW201940193A (zh) 2019-10-16
DK3010539T3 (da) 2019-10-21
LT3010539T (lt) 2019-10-10
JP6898421B2 (ja) 2021-07-07
JP2020073525A (ja) 2020-05-14
NZ752224A (en) 2020-11-27
NZ631118A (en) 2019-05-31
HRP20191709T1 (hr) 2019-12-13
PT3010539T (pt) 2019-10-14
JP2019069987A (ja) 2019-05-09
JP2021138743A (ja) 2021-09-16
TWI707694B (zh) 2020-10-21
JP6640977B2 (ja) 2020-02-05
SG10201912898XA (en) 2020-02-27

Similar Documents

Publication Publication Date Title
HK1222567A1 (zh) 通過施用 拮抗劑治療鼻息肉症的方法
HRP20181963T1 (hr) Postupci za liječenje ili sprječavanje astme primjenom antagonista il-4r
IL252228A0 (en) Methods for treating chronic sinusitis with nasal polyps by adding an il-4r antagonist
PL3107575T3 (pl) Sposoby leczenia lub zapobiegania astmie przez podawanie antagonisty IL-4R
PT3110848T (pt) Métodos para tratamento de infeção cutânea por administração de um antagonista do il-4r
HRP20182145T1 (hr) Antitumorni agens koji uključuje irinotekan hidroklorid hidrat u niskoj dozi
EP2968458A4 (en) DOSAGE SCHEME FOR THERAPEUTIC PROCESS
SG10201912898XA (en) Methods for treating nasal polyposis by administering an il-4r antagonist
IL271284A (en) Methods for treating or preventing asthma by administering an antagonist to -il-r4
IL285483A (en) Methods for the treatment of chronic sinusitis with nasal polyps by adding an il-4r antagonist
IL246913A0 (en) Methods for treating dermatitis by administering an antagonist to -il-4r
IL247290A0 (en) Methods of treating or preventing asthma by adding an il-4r antagonist